J. B. Chemicals & Pharmaceuticals Limited
JBCHEPHARM
Rankning i aktier
#3894
J. B. Chemicals & Pharmaceuticals Limited, an enterprise founded in Mumbai,... J. B. Chemicals & Pharmaceuticals Limited, an enterprise founded in Mumbai, India, in 1976, specializes in the development, production, and global distribution of diverse pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients. Among its prominent product offerings are Cilnidipine, Ranitidine, and Metronidazole. Beyond its own brands, the company extends comprehensive contract manufacturing services, covering an extensive spectrum of dosage forms such as tablets, various lozenge types, injectables, gels, creams, ointments, liquid herbal syrups, and capsules. The firm further contributes to diagnostic medicine by supplying contrast agents for advanced imaging techniques like X-ray, MRI, and ultrasound. Its therapeutic expertise encompasses a broad range of medical fields, including gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives, and pharmacovigilance.
Aktiekurs
$26.58
Senast synkroniserad: 2026-07-23
Marknadsvärde
$4.24B
Förändring (1 dag)
0.00%
Förändring (1 år)
38.40%
Land
IN
Handel J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM)
Kategori
Healthcare
P/S-tal för J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM)
P/S-tal per October 2026 TTM: 9.35
Enligt J. B. Chemicals & Pharmaceuticals Limited senaste finansiella rapporter och aktiekurs är det aktuella P/S-talet (TTM) 9.35. I slutet av 2024 hade företaget ett P/S-tal på 7.54.
Historik för P/S-tal för J. B. Chemicals & Pharmaceuticals Limited från 2005 till 2026
P/S-tal vid årets slut
| År | P/S-tal | Ändra |
|---|---|---|
| 2026 (TTM) | 9.35 | 48.93% |
| 2025 | 6.28 | -16.71% |
| 2024 | 7.54 | 53.78% |
| 2023 | 4.90 | -2.38% |
| 2022 | 5.02 | 3.84% |
| 2021 | 4.84 | 110.26% |
| 2020 | 2.30 | 21.87% |
| 2019 | 1.89 | -0.31% |
| 2018 | 1.89 | -15.47% |
| 2017 | 2.24 | 23.70% |
| 2016 | 1.81 | 12.32% |
| 2015 | 1.61 | 39.47% |
| 2014 | 1.16 | 40.76% |
| 2013 | 0.82 | 27.61% |
| 2012 | 0.64 | -51.50% |
| 2011 | 1.33 | 64.39% |
| 2010 | 0.81 | 88.62% |
| 2009 | 0.43 | -42.68% |
| 2008 | 0.75 | -40.69% |
| 2007 | 1.26 | -36.45% |
| 2006 | 1.98 | 7.09% |
| 2005 | 1.85 | 0.00% |
P/S-tal för liknande företag eller konkurrenter
| Företag | P/S-tal | Skillnad i P/S-tal | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | -24.54% |
IN
|
